Drug-induced anaphylaxis - Case/non-case study based on an Italian pharmacovigilance database

被引:47
|
作者
Leone, R
Conforti, A
Venegoni, M
Motola, D
Moretti, U
Meneghelli, F
Cocci, F
Cellini, GS
Scotto, S
Montanaro, N
Velo, G
机构
[1] Univ Verona, Clin Pharmacol Unit, WHO Programme Int Drug Monitoring, Reference Ctr Educ & Commun, I-37100 Verona, Italy
[2] Lombardy Ctr Pharmacovigilance, Milan, Italy
[3] Univ Bologna, Dept Pharmacol, Interuniv Res Ctr Pharmacoepidemiol, Bologna, Italy
关键词
D O I
10.2165/00002018-200528060-00006
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Objective: To identify the number of cases of anaphylaxis reported in association with different classes of drugs and compare it with other reports contained in the same database. Methods: The data were obtained from a database containing all of the spontaneous reports of adverse drug reactions (ADRs) coming from the Italian regions of Emilia Romagna, Lombardy and the Veneto, which are the main contributors to the Italian spontaneous surveillance system. The ADRs reported between January 1990 and December 2003 with a causality assessment of certainly, probably or possibly drug related (according to the WHO criteria) were analysed using a case/ non-case design. The cases were defined as the reactions already coded by the WHO preferred terms of 'anaphylactic shock' or 'anaphylactoid reaction' (this last term also included anaphylactic reaction) and those with a time of event onset that suggested an allergic reaction and involved at least two of the skin, respiratory, gastrointestinal, CNS or cardiovascular systems; the non-cases were all of the other ADR reports. The frequency of the association between anaphylaxis and the suspected drug in comparison with the frequency of anaphylaxis associated to all of the other drugs was calculated using the ADR reporting odds ratio (ROR) as a measure of disproportionality. Results: Our database contained 744 cases (including 307 cases of anaphylactic shock with 10 deaths) and 27 512 non-cases. The percentage of anaphylaxis cases reported in inpatients was higher than that among outpatients (59. 1 % vs 40.9%). This distribution is significantly different from that of the other ADR reports that mainly refer to outpatients. After intravenous drug administrations, anaphylactic shock cases were more frequent than anaphylactoid reactions or other ADRs, but more than one-third of these reactions were caused by an oral drug. Blood substitutes and radiology contrast agents had the highest RORs. Among the systemic antibacterial agents, anaphylaxis was disproportionally reported more often for penicillins, quinolones, cephalosporins and glycopeptides, but diclofenac was the only NSAID with a significant ROR. As a category, vaccines xhad a significantly lower ROR, thus indicating that anaphylaxis is reported proportionally less than other ADRs, Conclusions: Anaphylaxis is a severe ADR that may also occur with commonly used drugs. It represents 2.7% of all of the ADRs reported in an Italian spontaneous reporting database.
引用
收藏
页码:547 / 556
页数:10
相关论文
共 50 条
  • [1] Drug-Induced AnaphylaxisCase/Non-Case Study Based on an Italian Pharmacovigilance Database
    Roberto Leone
    Anita Conforti
    Mauro Venegoni
    Domenico Motola
    Ugo Moretti
    Ilaria Meneghelli
    Alfredo Cocci
    Giulia Sangiorgi Cellini
    Stefania Scotto
    Nicola Montanaro
    Giampaolo Velo
    [J]. Drug Safety, 2005, 28 : 547 - 556
  • [2] Drug-induced dementia:: a case/non-case study in the french pharmacovigilance database
    Favreliere, S.
    Brunet, G.
    Saulnier, P. J.
    Merlet, I.
    Alkhidir, F.
    Perault-Pochat, M. C.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2007, 21 : 68 - 68
  • [3] Drug-induced dementia:: A case/non-case study in the French pharmacovigilance database
    Favreliere, Sylvie
    Lafay-Chebassier, Claire
    Alkhidir, Fuad
    Merlet, Isabelle
    Pochat, Marie-Christine Perault
    [J]. THERAPIE, 2007, 62 (06): : 507 - 511
  • [4] Drug-induced hyperprolactinaemia: A case/non-case study in the French pharmacovigilance database
    Petit, A
    Piednoir, D
    Germain, ML
    Trenque, T
    [J]. THERAPIE, 2003, 58 (02): : 159 - 163
  • [5] Drug-induced hearing loss: a case/non-case study in the French pharmacovigilance database
    Favreliere, Sylvie
    Delaunay, Paul
    Lebreton, Jean-Pascal
    Rouby, Franck
    Atzenhoffer, Martine
    Lafay-Chebassier, Claire
    Perault-Pochat, Marie Christine
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2020, 34 (03) : 397 - 407
  • [6] Drug-induced retroperitoneal fibrosis: a case/non-case study in the French PharmacoVigilance Database
    Brasselet, Diana
    Chouchana, Laurent
    Vial, Thierry
    Damin-Pernik, Marlene
    Lebrun-Vignes, Benedicte
    [J]. EXPERT OPINION ON DRUG SAFETY, 2020, 19 (07) : 903 - 913
  • [7] DRUG-INDUCED RESTLESS LEGS SYNDROME: A CASE/NON-CASE STUDY IN THE FRENCH PHARMACOVIGILANCE DATABASE
    Perez-Lloret, S.
    Rascol, O.
    Montastruc, J. -L.
    [J]. EUROPEAN JOURNAL OF NEUROLOGY, 2011, 18 : 56 - 56
  • [8] Drug-induced vitiligo: a case/non-case study in Vigibase(R), the WHO pharmacovigilance database
    Anthony, Norah
    Bourneau-martin, Delphine
    Ghamrawi, Sarah
    Lagarce, Laurence
    Babin, Marina
    Briet, Marie
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2020, 34 (06) : 736 - 742
  • [9] Drug-induced Sweet's syndrome: A case/non-case study in the French pharmacovigilance database
    Martin, Salome
    Trenque, Thierry
    Herlem, Emmanuelle
    Boulay, Charlene
    Pizzoglio, Veronique
    Azzouz, Brahim
    [J]. BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2024, 90 (08) : 1873 - 1879
  • [10] Drug-induced gingival bleeding: a case/non-case study from the French Pharmacovigilance Database
    Bondon-Guitton, E.
    Mourgues, T.
    Rousseau, V.
    Jean-Pastor, M. J.
    Cottin, J.
    Drablier, G.
    Montastruc, J. L.
    [J]. FUNDAMENTAL & CLINICAL PHARMACOLOGY, 2015, 29 : 3 - 4